IMUXNasdaqPharmaceutical PreparationsFiscal year ends December 31

IMMUNIC, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026

$6.99+0.02 (+0.29%)

Close on Oct 19, 2026

Market cap: $297.17M
P/E (TTM): –
Dividend yield: 0.00%

IMMUNIC, INC. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	Q2 2026 2026-06-30	Q1 2026 2026-03-31	Q4 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30	Q1 2025 2025-03-31	Q4 2024 2024-12-31	Q3 2024 2024-09-30	Q2 2024 2024-06-30	Q1 2024 2024-03-31	Q4 2023 2023-12-31	Q3 2023 2023-09-30	Q2 2023 2023-06-30	Q1 2023 2023-03-31	Q4 2022 2022-12-31	Q3 2022 2022-09-30	Q2 2022 2022-06-30	Q1 2022 2022-03-31	Q4 2021 2021-12-31	Q3 2021 2021-09-30	Q2 2021 2021-06-30	Q1 2021 2021-03-31	Q4 2020 2020-12-31	Q3 2020 2020-09-30	Q2 2020 2020-06-30	Q1 2020 2020-03-31	Q4 2019 2019-12-31	Q3 2019 2019-09-30	Q2 2019 2019-06-30	Q1 2019 2019-03-31	Q4 2018 2018-12-31	Q3 2018 2018-09-30	Q2 2018 2018-06-30	Q1 2018 2018-03-31	Q4 2017 2017-12-31	Q3 2017 2017-09-30	Q2 2017 2017-06-30	Q1 2017 2017-03-31	Q4 2016 2016-12-31	Q3 2016 2016-09-30
Cash & Equivalents	155	187	15	35	55	14	36	59	80	97	47	60	77	93	107	73	88	96	87	110	87	115	127	133	49	19	29	30	36	7.59	13	10	12	44	4.50	66	76	87	60	68
Cash & Short-Term Investments	155	187	15	35	55	14	36	59	80	97	47	60	77	93	107	73	88	96	87	110	87	115	127	133	49	19	29	30	36	7.59	13	10	12	44	4.50	66	76	87	60	68
Prepaid Expenses & Other	2.74	2.13	7.39	4.14	4.53	4.67	3.66	4.20	5.28	5.30	5.86	5.55	9.26	9.47	9.49	14	17	20	18	12	15	5.44	6.29	4.36	4.42	5.02	2.86	4.06	2.45	0.39	0.26	1.26	1.53	1.19	1.22	1.57	1.91	1.67	1.47	1.36
Other Current Assets	0.85	1.06	0.83	0.82	0.86	1.25	1.11	0.76	1.06	1.09	1.07	1.45	1.39	1.90	1.23	1.55	1.52	1.55	1.12	1.28	1.50	0.89	1.23	0.60	0.66	0.67	0.80	–	–	–	0.07	–	–	–	–	–	–	–	–	–
Total Current Assets	158	189	23	39	60	19	39	63	85	103	53	65	87	107	126	87	105	116	105	122	102	120	134	138	53	24	32	35	39	9.99	13	19	33	45	58	68	78	88	61	69
Property, Plant & Equipment	0.77	0.57	0.61	0.64	0.61	0.57	0.55	0.62	0.59	0.44	0.47	0.29	0.29	0.29	0.29	0.16	0.14	0.16	0.15	0.20	0.19	0.19	0.20	0.15	0.12	0.08	0.08	0.04	0.04	0.48	0.04	0.89	2.06	2.07	2.16	2.27	2.43	2.49	2.51	2.92
Gross Property, Plant & Equipment	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	10	11	12	13	13	12	13	13	12	12	12
Accumulated Depreciation	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	-9.80	-11	-11	-11	-11	-10	-10	-10	-9.94	-9.60	-9.41
Operating Lease Right-of-Use Assets	0.57	0.42	0.58	0.79	0.98	0.97	0.99	0.88	0.93	1.10	1.30	1.41	1.86	1.96	1.55	1.26	0.75	0.87	0.95	1.05	1.17	1.24	0.90	0.94	1.00	0.60	0.63	0.07	0.07	0.01	–	–	–	–	–	–	–	–	–	–
Goodwill	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	33	33	33	33	33	33	33	33	33	33	33	33	33	33	–	0	–	–	–	–	–	–	–	–	–
Other Long-Term Assets	–	–	–	–	–	–	–	–	–	–	0	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	–	–	0.01	0	0.04	0.10	0.10	0.11	0.13	0.18	0.16	0.06	0.09
Total Assets	159	190	24	41	61	21	41	65	86	104	54	67	89	109	128	121	139	150	139	157	136	155	168	172	87	57	66	68	73	10	13	20	35	47	60	70	81	91	64	72
Accounts Payable	13	11	10	7.92	7.89	6.01	7.85	6.04	7.89	6.77	5.10	3.20	4.70	5.24	4.28	4.17	4.12	3.29	3.75	3.24	4.18	10	3.70	3.42	1.73	1.43	2.42	3.72	1.46	0.18	1.40	1.13	1.08	0.89	1.05	0.98	1.08	1.31	0.78	1.19
Accrued Expenses	18	22	19	19	18	18	13	16	14	12	19	14	13	10	7.99	6.62	5.74	7.52	7.07	6.77	6.18	5.83	4.32	4.25	5.45	3.96	3.30	3.24	1.59	1.22	0.42	4.55	7.19	8.70	9.14	7.17	6.15	5.09	4.66	3.36
Current Portion of Leases	0.24	0.28	0.47	0.67	0.77	0.77	0.74	0.71	0.71	0.70	0.70	0.66	0.67	0.65	0.57	0.40	0.37	0.40	0.41	0.41	0.19	0.39	0.30	–	–	–	–	–	–	0.03	0.02	–	–	–	0.09	–	–	–	–	–
Other Current Liabilities	0.74	4.92	1.84	2.71	1.31	1.29	1.42	1.07	1.01	0.96	0.97	0.92	0.93	0.88	0.81	0.72	0.54	0.65	0.59	0.58	4.13	0.48	0.38	0.36	0.50	0.94	1.35	0.08	0.07	0.03	0.10	0.01	0.04	0.07	0.09	0.09	0.07	0.06	0.04	0.08
Total Current Liabilities	31	38	31	30	27	26	22	23	23	20	25	18	18	16	13	12	10	11	11	11	14	16	8.40	8.03	7.67	6.33	7.07	7.04	3.12	1.43	1.92	5.69	8.30	9.67	10	8.23	7.29	6.45	5.48	4.63
Long-Term Leases	0.33	0.15	0.11	0.13	0.21	0.21	0.26	0.19	0.24	0.43	0.64	0.79	1.21	1.35	0.99	0.76	0.41	0.50	0.58	0.70	0.83	0.92	0.68	0.74	0.79	0.47	0.52	–	–	–	0.04	–	–	–	0.06	–	–	–	–	–
Operating Lease Liabilities	0.57	0.42	0.58	0.79	0.98	0.98	1.00	0.90	0.96	1.13	1.33	1.45	1.88	2.00	1.54	1.27	0.77	0.91	1.02	1.14	1.22	1.35	0.97	1.00	1.08	0.67	0.69	0.07	0.07	0.03	0.06	–	–	–	0.15	–	–	–	–	–
Other Long-Term Liabilities	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.04	0.04	–	0	–	–	–	–	–	–	–	0.10	–
Total Liabilities	32	39	31	30	28	26	22	24	23	21	25	19	19	18	14	12	11	12	12	11	15	17	9.08	8.77	8.47	6.80	7.59	7.08	3.16	20	1.92	41	54	63	74	8.28	7.34	6.52	5.58	4.71
Preferred Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Additional Paid-In Capital	800	789	599	597	595	528	526	524	522	520	436	434	432	430	428	370	368	356	324	322	279	277	267	257	160	121	120	115	114	356	0.06	349	349	348	346	343	342	341	302	300
Retained Earnings	-675	-641	-609	-589	-564	-537	-511	-486	-462	-440	-411	-389	-367	-343	-317	-261	-240	-218	-197	-176	-156	-138	-104	-93	-80	-68	-60	-52	-44	-347	-25	-335	-323	-310	-296	-281	-269	-256	-244	-232
Comprehensive Income & Other	2.77	3.06	2.65	2.58	2.53	3.92	4.21	3.89	3.78	4.29	3.76	3.91	3.98	3.81	3.04	-0.39	-0.66	-0.31	-0.25	-0.80	-1.40	-1.12	-4.11	-1.75	-1.61	-1.68	-1.37	-1.80	-0.72	0.08	-0.82	0.08	0.08	0.08	0.08	0.09	0.09	0.08	0.08	0.08
Shareholders' Equity	128	151	-6.67	10	34	-5.29	18	41	64	84	29	48	69	91	114	109	128	138	127	145	121	137	159	163	79	50	58	61	69	-9.77	-26	-21	-19	-16	-13	62	73	84	58	68
Total Equity	128	151	-6.67	10	34	-5.29	18	41	64	84	29	48	69	91	114	109	128	138	127	145	121	137	159	163	79	50	58	61	69	-9.77	-26	-21	-19	-16	-13	62	73	84	58	68
Total Liabilities & Equity	159	190	24	41	61	21	41	65	86	104	54	67	89	109	128	121	139	150	139	157	136	155	168	172	87	57	66	68	73	10	13	20	35	47	60	70	81	91	64	72
Shares Outstanding(shares)	14	14	12	9.87	9.87	9.02	9.02	9.01	9.01	9.01	4.52	4.46	4.45	4.44	3.93	3.06	3.06	2.92	2.63	2.62	2.17	2.17	2.12	2.07	1.50	1.08	1.07	1.01	1.00	0.08	0.08	0.08	0.08	0.08	0.08	0.08	0.08	0.08	0.06	0.06

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -1653.1%

Financial strength

Current ratio: 5.05
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 496.2%

Valuation

P/E ratio: –
Price to sales: –
Price to book: 2.33
Dividend yield: 0.00%